Journal of the National Cancer Institute
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
115:1605-1615.
2023
-
Cancer equity for those impacted by mass incarceration.
115:1128-1131.
2023
-
A polygenic two-hit hypothesis for prostate cancer.
115:468-472.
2023
-
Do Breast Cancer Risk Scores Work for You?.
113:1118-1119.
2021
-
Performance of Digital Breast Tomosynthesis, Synthetic Mammography, and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis.
113:680-690.
2021
-
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
113:390-399.
2021
-
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review.
113:123-136.
2021
-
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32.
113:192-198.
2021
-
International Trends in the Incidence of Cancer Among Adolescents and Young Adults.
112:1105-1117.
2020
-
Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.
111:727-736.
2019
-
RE: A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
111:633-634.
2019
-
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology.
111:118-128.
2019
-
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.
110:1370-1379.
2018
-
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
110:1360-1369.
2018
-
Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.
110:661-668.
2018
-
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.
108:djw037-djw037.
2016
-
Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12.
107:djv106.
2015
-
Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32.
107:djv006-djv006.
2015
-
The Bipartisan Colon.
107:djv011-djv011.
2015
-
Use and Misuse of Waterfall Plots.
106:dju331.
2014
-
Risk of Premature Menopause After Treatment for Hodgkin's Lymphoma.
106:dju231-dju231.
2014
-
Phase II Study of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage T1-3 N0 M0 Non-Small Cell Lung Cancer: NCIC CTG BR.25.
106:dju164-dju164.
2014
-
Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials.
106:dju132.
2014
-
Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute-Sponsored Trials.
105:954-959.
2013
-
A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer.
105:551-562.
2013
-
Enhancing Citizen Engagement in Cancer Screening Through Deliberative Democracy.
105:380-386.
2013
-
Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review.
104:982-989.
2012
-
Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer.
104:590-598.
2012
-
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis.
104:18-28.
2012
-
Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009).
103:178-231.
2011
-
Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel.
102:1547-1556.
2010
-
Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial.
102:859-865.
2010
-
Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer.
102:298-306.
2010
-
Response: Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy.
101:1736-1737.
2009
-
Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial.
101:1182-1192.
2009
-
Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy.
101:644-650.
2009
-
Response: Re: Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?.
100:1559-1560.
2008
-
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers.
100:1361-1367.
2008
-
Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women.
100:898-905.
2008
-
Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?.
100:773-783.
2008
-
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review.
99:1753-1767.
2007
-
Re: Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women.
99:408-409.
2007
-
Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV ΔM51 ) on Multifocal and Invasive Gliomas.
98:1546-1557.
2006
-
Human Papillomavirus Triage of Atypical Squamous Cells of Undetermined Significance: Cost-Effective, But At What Cost?.
98:82-83.
2006
-
RESPONSE: Re: A Structured Review of Studies on Health-Related Quality of Life and Economic Evaluation in Pediatric Acute Lymphoblastic Leukemia.
97:1786-1787.
2005
-
Re: A Structured Review of Studies on Health-Related Quality of Life and Economic Evaluation in Pediatric Acute Lymphoblastic Leukemia.
97:1786-1786.
2005
-
More Evidence That Locoregional Radiation Therapy Improves Survival: What Should We Do?.
97:82-84.
2005
-
Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors.
97:59-69.
2005
-
Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene.
96:1751-1761.
2004
-
RESPONSE: Re: Consolidation Therapy With Autologous Bone Marrow Transplantation in Adults With Acute Myeloid Leukemia: A Meta-analysis.
96:1039-1040.
2004
-
Re: Consolidation Therapy With Autologous Bone Marrow Transplantation in Adults With Acute Myeloid Leukemia: A Meta-analysis.
96:1038-1039.
2004
-
Re: Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus.
96:885-887.
2004
-
Workshop on Partial Breast Irradiation: State of the Art and the Science, Bethesda, MD, December 8-10, 2002.
96:175-184.
2004
-
Consolidation Therapy With Autologous Bone Marrow Transplantation in Adults With Acute Myeloid Leukemia: A Meta-analysis.
96:38-45.
2004
-
Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer.
95:1482-1485.
2003
-
Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women.
95:1218-1226.
2003
-
RESPONSE: Re: Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer.
95:759-759.
2003
-
Re: Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer.
95:759-759.
2003
-
Re: Is Less More? Lessons in Radiation Schedules in Breast Cancer.
95:685-686.
2003
-
Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer.
95:581-587.
2003
-
Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock.
95:263-281.
2003
-
Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status.
94:1504-1506.
2002
-
Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer.
94:1143-1150.
2002
-
Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies.
94:606-616.
2002
-
Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer.
93:1754-1754.
2001
-
Erythrocyte Membrane Fatty Acids and Subsequent Breast Cancer: a Prospective Italian Study.
93:1088-1095.
2001
-
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer.
93:605-618.
2001
-
Methodology for Treatment Evaluation in Patients With Cancer Metastatic to Bone.
93:534-538.
2001
-
Large Nontransplanted Hepatocellular Carcinoma in Woodchucks: Treatment With Adenovirus-Mediated Delivery of Interleukin 12/B7.1 Genes.
93:472-479.
2001
-
Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer.
92:1321-1329.
2000
-
Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update.
88:1659-1664.
1996
-
Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group..
88:1659-1664.
1996
-
Development of Retinoblastoma in the Absence of Telomerase Activity.
88:1152-1157.
1996
-
Epidemiology of Brain Lymphoma Among People With or Without Acquired Immunodeficiency Syndrome.
88:675-679.
1996
-
Serum Sex Hormone Levels After Menopause and Subsequent Breast Cancer.
88:291-297.
1996
-
BOOK REVIEW.
86:1641-1641.
1994
-
Financial Concerns Prompt Sponsoring Pharmaceutical Company to Halt International Phase I Studies.
86:1353-1353.
1994
-
Phase II Trial of 13-cis-Retinoic Acid Plus Interferon in Non-Small-Cell Lung Cancer: For the National Cancer Instit ute of Canada Clinical Trials Group.
86:306-309.
1994
-
Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian Carcinoma.
85:823-825.
1993
-
Quality-of-Life Assessment: Patient Compliance With Questionaire Completion.
84:1023-1026.
1992
-
Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Disection for Node-Negative Breast Cancer.
84:683-689.
1992
-
Phase I Trial of Granulocyte-Macrophage Colony-Stimulating Factor With High-Dose Cisplatin and Etoposide for Treatment of Small-Cell Lung Cancer: A Study of the National Cancer Institute of Canada Clinical Trials Group.
84:59-60.
1992
-
Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor.
83:1748-1753.
1991
-
Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis.
83:1169-1173.
1991
-
Increased DNA Synthesis and Repair-Enzyme Expression in Lymphocytes From Patients With Chronic Lymphocytic Leukemia Resistant to Nitrogen Mustards.
83:557-564.
1991
-
Etretinate Blood Levels in Monitoring of Compliance and Contamination in a Chemoprevention Trial.
81:795-798.
1989
-
Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer..
71:941-944.
1987
-
Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma..
71:981-982.
1987
-
Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung..
71:575-580.
1987
-
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin..
71:277-281.
1987
-
Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study..
70:1029-1030.
1986
-
Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma..
69:727-728.
1985
-
Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report..
69:240-241.
1985
-
Effect of adjuvant central iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial..
69:167-177.
1985
-
Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma..
69:227-228.
1985
-
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma..
69:209-210.
1985
-
A Mortality Study of 11,500 Nickel Workers<xref ref-type="fn" rid="FN2">2</xref>.
73:1251-1258.
1984
-
Enhanced Natural Killer Sensitivity With Concomitant Clonal Selection for Cells Bearing Homogeneously Staining Regions in the Human Melanoma Cell Line MeWo Upon Induction of Differentiation With Theophylline<xref ref-type="fn" rid="FN2">2</xref>.
72:991-998.
1984
-
Amplified <italic>Kpn</italic>I Repetitive DNA Sequences in Homogeneously Staining Regions of a Human Melanoma Cell Line<xref ref-type="fn" rid="FN2">2</xref>.
72:801-808.
1984
-
Amplified KpnL repetitive DNA sequences in homogeneously staining regions of a human melanoma cell line..
72:801-808.
1984
-
GLUCOCORTICOID BINDING-PROPERTIES OF MOUSE THYMIC LYMPHOSARCOMA CELL-POPULATIONS SELECTED FOR RESISTANCE TO THE CYTOLYTIC EFFECTS OF GLUCOCORTICOIDS INVIVO.
71:579-582.
1983
-
Epileptic seizures associated with cisplatin administration..
66:1719-1722.
1982
-
Soft-Tissue Necrosis Induced by Extravasated Cancer Chemotherapeutic Agents2, 3.
66:1129-1136.
1981
-
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma..
65:947-954.
1981
-
Treatment of central nervous system tumors with methotrexate..
65 Suppl 1:137-140.
1981
-
Tobacco Use, Occupation, Coffee, Various Nutrients, and Bladder Cancer<xref ref-type="fn" rid="FN2">2</xref>.
64:701-713.
1980
-
NON-MUTATIONAL ALTERATION IN GLUCOCORTICOID SENSITIVITY OF LYMPHOSARCOMA-P1798.
64:55-62.
1980
-
Karyometry in the Estimation of Nuclear Population in Pulmonary Carcinomas2.
52:1699-1704.
1974
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)